After Hours Gainers:
Companies trading higher in after hours in reaction to earnings/guidance: CRON +0.8%
Companies trading higher in after hours in reaction to news: CTMX +11.9% (achieves clinical milestone CX-2029 program, triggering a $40 mln payment from AbbVie), CVLT +7.3% (Starboard (Jeffrey Smith) discloses 9.3% active stake), CSPR +2.7% (extends closure of North America retail stores), BA +0.9% (awarded $1.6 bln Navy contract modification), SGMS +0.8% (issues statement on COVID-19 response)
After Hours Losers:
Companies trading lower in after hours in reaction to earnings/guidance: RH -10.5%
Companies trading lower in after hours in reaction to news: AMRN -68% (reports of an unfavorable patent ruling for Vascepa), RETA -10.5% (provides COVID-19 update in connection with clinical programs; to stop Phase 3 CATALYST study), SVRA -8.5% (terminates enrollment in Phase 3 AVAIL and Phase 2a ENCORE studies due to COVID-19), PLNT -6.1% (withdraws guidance, says stores will remain closed until further notice), DPZ -4.8% (says Q1 comps were +1.6% at US stores, US sales were impacted by many factors), LC -3.5% (provides update on effects of the coronavirus), PZZA -2.6% (founder John H. Schnatter lowers active stake), ADC -2% (commences public offering of 2.5 mln shares), PDM -1.5% (still evaluating impact on the co's earnings projection), HIBB -1.2% (names Robert Volke as CFO), MRSN -0.9% (reports updated data from Phase 1 dose escalation study of XMT-1536)
After Hours Summary: RH -10.5% down big on earnings; AMRN down sharply on reports of an unfavorable patent ruling for Vascepa